VRTX 241227 445.00P (VRTX241227P445000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

VRTX241227P445000

Watchlist

33.00
-8.20-19.90%

15min DelayClose Dec 24 13:00 ET

39.12High33.00Low

Intraday

5D
Daily

News

Will Vertex Pharmaceuticals Incorporated (VRTX) Make You Rich In 2025?
Yahoo Finance23:02 ET
Vertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know
Yahoo Finance17:50 ET
Top Stock Reports for T-Mobile, Toyota Motor & Vertex Pharmaceuticals
Zacks 14:00 ET
Vertex Pharmaceuticals Price Target Lowered to $460 From $550 at Truist
Yahoo FinanceDec 24 09:50 ET
Truist has lowered the Vertex Target Price to 460 dollars.
Truist: lowered the Target Price of Vertex Pharmaceuticals from $550 to $460, maintaining a Buy rating. (Gelonghui)
Gelonghui FinanceDec 24 08:24 ET
A Quick Look at Today's Ratings for Vertex Pharmaceuticals(VRTX.US), With a Forecast Between $430 to $525
Moomoo NewsDec 24 08:00 ET · Ratings

Comments

Lnova

Dec 19 18:23

$Vertex Pharmaceuticals (VRTX.US)$
nfa

Vertex Stock Plunges 13% Over Pain Drug's Disappointing Study Results

Lnova

Dec 19 18:19

“SiteOne Therapeutics Announces a $100 Million Series C Financing to Advance Selective Ion Channel Modulators as Non-Opioid Treatments for Pain.
SiteOne’s efforts in non-opioid pain management put it in a unique position relative to Vertex Pharmaceuticals, a major player in the field known for its successful development of cystic fibrosis treatments. Vertex has also been working on non-opioid pain drugs, specifically targeting the NaV1.8 sodium channel, a focal point shared by SiteOne’s lead pro...

SiteOne Therapeutics Announces a $100 Million Series C Financing to Advance Selective Ion Channel Modulators as Non-Opioid Treatments for Pain

Kevin Travers

Nov 15 15:20

Columns Market Falls to End All-Time High Week | Wall Street Today

In the end, a week that starts with an all-time high for the S&P 500, Dow Jones, and Nasdaq 100, ended with equities lower.
At 4:02 p.m. ET, the three indices closed lower. The $Dow Jones Industrial Average (.DJI.US)$ was off 0.70%, losing 300 points. The $S&P 500 Index (.SPX.US)$ was down 1.32% and the $Nasdaq Composite Index (.IXIC.US)$ was off 2.24%.
MACRO
In macro, core retail sales grew by 0.1% month over month, lower than estimated. ...

Live Stock Financial Podcast. What are you watching on the market?

Kevin Travers

Nov 15 10:12

Columns Market Falls Friday on Earnings | Live Stock

You will not get through the trading day without the news and animal spirits guiding the market. It is finally Friday, November 15th.
My name is Kevin Travers and the market is falling today- here is why.
$Alibaba (BABA.US)$ shares declined after a report from the firm Friday morning that it was facing a consumer demand slump, even though its AI cloud business grew 7% to $4.2B in its second fiscal quarter.
$Applied Materials (AMAT.US)$ fell 8% after r...

Powell says no hurry for Fed rate cuts, how will you adjust your investment strategy?

Nnuge

Nov 11 03:16

Golden Cross

The indication of a golden cross is usually a strong buying signal. I like that Vertex is in the late stages of developing a cure for diabetes!

Paper Trading Competition: Share your P/L orders and elevate your trading skills